Maryland, MD—United States Pharmacopeia (USP) Healthcare Quality and Safety (HQS) Center of Excellence is examining the current landscape of Digital Therapeutics (DTx) to establish quality standards aimed at broadening access and ensuring appropriate use of these therapeutics. 

In 2022, more than 8,000 people in the Kyrgyz Republic developed tuberculosis (TB), including

Drug shortages pose a significant, ongoing threat to our healthcare system and to the patients who rely on medicine for their wellbeing and survival.

In April, the World Health Organization (WHO) became the latest health authority to release a draft guidance on Current Good Manufacturing Practices (CGMP) considerations for the prevention and management of nitrosamine contamination in pharmaceutical products.